Canada markets close in 4 hours 26 minutes

Luye Pharma Group Ltd. (LUP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.3500+0.0060 (+1.74%)
As of 08:03AM CEST. Market open.
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
6,143,078
6,143,078
5,981,656
5,200,226
5,539,641
Cost of Revenue
1,938,903
1,938,903
1,841,140
1,803,486
1,549,027
Gross Profit
4,204,175
4,204,175
4,140,516
3,396,740
3,990,614
Operating Expenses
Research Development
586,157
586,157
857,337
683,156
789,869
Selling General and Administrative
2,700,134
2,700,134
2,402,561
2,275,624
2,185,375
Total Operating Expenses
3,175,450
3,175,450
3,186,638
3,113,934
2,775,351
Operating Income or Loss
1,028,725
1,028,725
953,878
282,806
1,215,263
Interest Expense
675,454
675,454
471,755
399,458
424,002
Income Before Tax
700,100
700,100
669,762
-74,557
942,174
Income Tax Expense
161,023
161,023
86,466
70,226
238,909
Income from Continuing Operations
539,077
539,077
583,296
-144,783
703,265
Net Income
532,605
532,605
604,807
-134,392
706,586
Net Income available to common shareholders
532,605
532,605
604,807
-134,392
706,586
Basic EPS
0.13
-
0.17
-0.04
0.22
Diluted EPS
0.13
-
0.17
-0.04
0.22
Basic Average Shares
3,589,365
-
3,480,853
3,445,431
3,187,322
Diluted Average Shares
3,301,869
-
3,480,853
3,445,431
3,193,947